Wire Stories
Otsuka to Terminate Development of AVP-786
TOKYO & PRINCETON, N.J.–(BUSINESS WIRE)–Otsuka Pharmaceutical Co., Ltd. (Otsuka) and its U.S. subsidiary, Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) announce termination...